Skip to content
GLP-1 Desk
Menu
Dispatch #318

NowPatient

NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.

Visit NowPatientAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
Semaglutide
$1,349/mo (brand Wegovy)
Tirzepatide
$1,069/mo (brand Mounjaro, promotional rate)
Coverage
Coverage not published
Brand-name
Yes

Line NowPatient up against its closest alternatives. Or go one-on-one: NowPatient vs CoreAge Rx.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency38/100
State access24/100
Molecule range95/100
Onboarding speed66/100
Support responsiveness83/100
Licensing & trust80/100

What the Desk likes

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

Where points come off

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)

The Desk's briefing — C

Best for: Readers who want brand-name GLP-1 access without a compounded route.

NowPatient ranks #318 of 498 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Everyone else on the board (18)

Pricing and verification reflect NowPatient's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on NowPatient's site. Not medical advice; see our disclosure.

← Back to The Desk